FluidAI secures a $2 Million Government of Canada investment to accelerate global commercialization of AI-driven post operative care technology

FluidAI Medical has secured a $2-million investment from the Government of Canada to accelerate the global commercialization of its surgical care technology. The funding will be used to enhance FluidAI's manufacturing processes and expedite the commercialization of its advanced post-operative care technologies for global markets. FluidAI's Stream™ Care, which integrates state-of-the-art AI algorithms and advanced sensing hardware like Origin™, empowers healthcare professionals to make data-driven decisions that may aid them in improving patient outcomes and shortening hospital stays.

FluidAI Medical is an OBIO® member, an alumnus of our BDSP™, CAAP®, EAHN™, H2BB™, HealthMINT™, Life Sciences Critical Technologies & Commercialization (LSCTC) Centre of Excellence and WiHI programs, and presented at the OBIO® Investment Summit.